Mydecine Innovations Group gearing up for human trials after completing Aquis listing
–News Direct– Mydecine Innovations Group Inc (OTC:MYCOF, NEO:MYCO) CEO Joshua Bartch speaks to Thomas Warner from Proactive London about the biotechnology company's ambitious goals in …